Stem Cell Transplantation Unit, Department of Haematology, University of Brescia, Piazzale Spedali Civili 1, Brescia, Italy.
Bone Marrow Transplant. 2009 Dec;44(11):729-37. doi: 10.1038/bmt.2009.80. Epub 2009 Apr 27.
The role of different cytokines and cells of immune system in the pathogenesis of chronic GVHD (cGVHD) is still controversial. Earlier studies, which were either retrospective or analysed one or a few factors, did not show unequivocal results. We prospectively evaluated cytokine levels and lymphocyte subsets in 30 patients who underwent Allo-SCT to investigate their possible correlation with cGVHD. Levels of IL-4, IL-6, IL-10, IFN-gamma, tumour necrosis factor-alpha (TNF-alpha) and its soluble receptors were assessed by ELISA in 30 patients at different times after SCT. Lymphocyte subsets were evaluated by flow cytometry in peripheral blood at the same times as cytokines. A multivariate analysis was performed using principal component analysis and multi-factor ANOVA (analysis of variance). Eighteen patients developed cGVHD at a median time of 6 months (range, 5-9) after SCT. In multivariate analysis, we observed a correlation between cGVHD and clusters of cytokines and lymphocyte subsets from the third to the sixth month after SCT. These clusters changed their composition over time, but they constantly included natural killer (NK) and CD152+ T cells as negative predictors of cGVHD. TNF-alpha prevailed among other cytokines before the onset of cGVHD. This prevalence could be related partly to the defect of immunoregulatory cells.
不同细胞因子和免疫系统细胞在慢性移植物抗宿主病(cGVHD)发病机制中的作用仍存在争议。之前的研究,无论是回顾性的还是分析一个或几个因素的,都没有得出明确的结果。我们前瞻性地评估了 30 例接受同种异体造血干细胞移植(Allo-SCT)患者的细胞因子水平和淋巴细胞亚群,以研究它们与 cGVHD 的可能相关性。在 SCT 后不同时间点,通过 ELISA 评估 30 例患者的 IL-4、IL-6、IL-10、IFN-γ、肿瘤坏死因子-α(TNF-α)及其可溶性受体水平。在同一时间点通过流式细胞术评估外周血淋巴细胞亚群。使用主成分分析和多因素方差分析(ANOVA)进行多变量分析。18 例患者在 SCT 后 6 个月(范围 5-9)中位数时间出现 cGVHD。在多变量分析中,我们观察到 cGVHD 与 SCT 后第 3 至第 6 个月的细胞因子和淋巴细胞亚群簇之间存在相关性。这些簇随着时间的推移改变了它们的组成,但它们始终包括自然杀伤(NK)和 CD152+T 细胞作为 cGVHD 的负预测因子。在 cGVHD 发生之前,TNF-α在其他细胞因子中占主导地位。这种优势可能部分与免疫调节细胞的缺陷有关。